drugset
drugset / Trial / NCT04425772

A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）

NCT04425772 ↗

Unknown 342 enrolled Henan Genuine Biotech Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the efficacy and safety of azvudine in treatment of COVID-19

Timeline

Start
2020-06-12
Primary completion
2020-08-12
Completion
2020-08-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Azvudine Small molecule — —

Indications

COVID-19